Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
IN |
|
Wasion Holdings Ltd
HKEX:3393
|
HK |
|
Intikeramik Alamasri Industri Tbk PT
IDX:IKAI
|
ID |
|
Apollo Future Mobility Group Ltd
HKEX:860
|
HK |
|
Marker Therapeutics Inc
NASDAQ:MRKR
|
US |
Wall Street
Price Targets
ZYDUSLIFE Price Targets Summary
Zydus Lifesciences Ltd
According to Wall Street analysts, the average 1-year price target for
ZYDUSLIFE
is 1 015.8 INR
with a low forecast of 858.5 INR and a high forecast of 1 376.55 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ZYDUSLIFE's stock price target?
Price Target
1 015.8
INR
According to Wall Street analysts, the average 1-year price target for
ZYDUSLIFE
is 1 015.8 INR
with a low forecast of 858.5 INR and a high forecast of 1 376.55 INR.
What is Zydus Lifesciences Ltd's Revenue forecast?
Projected CAGR
10%
For the last 13 years the
compound annual growth rate for
Zydus Lifesciences Ltd's revenue is
12%.
The projected
CAGR
for the next 3 years is
10%.
What is Zydus Lifesciences Ltd's Operating Income forecast?
Projected CAGR
0%
For the last 13 years the
compound annual growth rate for
Zydus Lifesciences Ltd's operating income is
15%.
The projected
CAGR
for the next 3 years is
0%.
What is Zydus Lifesciences Ltd's Net Income forecast?
Projected CAGR
1%
For the last 13 years the
compound annual growth rate for
Zydus Lifesciences Ltd's net income is
16%.
The projected
CAGR
for the next 3 years is
1%.
